ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

No reported Other Income / Expenses figures are available to summarize.

Other Income / Expenses history

Currency unavailable · from the income statement

No Other Income / Expenses data reported for this period type.

Other Income / Expenses vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Other Income / Expenses for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
STOKStoke Therapeutics, Inc.LTM Mar 2026$14.2M USD+6.7%+60.9%44.3%
WVEWave Life Sciences Ltd.LTM Mar 2026$13.29M USD-1.0%+91.1%18.5%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$10.54M USD-22.0%—23.2%
PRMEPrime Medicine, Inc.LTM Mar 2026$8.24M USD+88.4%—204.2%
BNTCBenitec Biopharma Inc.LTM Mar 2026$5.05M USD+38.6%——
SLNSilence Therapeutics plcLTM Mar 2026$1.43M USD—-50.1%155.2%
PRQRProQR Therapeutics N.V.LTM Mar 2026€840.44K EUR-70.3%+16.3%6.3%
RNAAtrium Therapeutics, Inc.FY2025-$12K USD——0.1%
MGTXMeiraGTx Holdings plcLTM Mar 2026-$15.34M USD-85.0%—19.2%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-1.0%+38.6%21.2%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.